{"disease":{"id":"motor-neuron-disease-amyotrophic-lateral-sclerosis","name":"motor neuron disease amyotrophic lateral sclerosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06885918","title":"ALS Research Collaborative","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"ALS Therapy Development Institute","has_results":false},{"nct_id":"NCT05852405","title":"Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Ambulanzpartner Soziotechnologie APST GmbH","has_results":false},{"nct_id":"NCT05136222","title":"Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":244,"lead_sponsor_name":"University of Melbourne","has_results":false},{"nct_id":"NCT06320444","title":"Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"University of Dublin, Trinity College","has_results":false},{"nct_id":"NCT03764384","title":"Validation Of Tidal/End -Tidal CO2 in ALS","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Papworth Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT04939818","title":"Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Novoic Limited","has_results":false},{"nct_id":"NCT04695210","title":"Virtual Peer-to-peer Support Programme for Carers of MND","phase":"NA","overall_status":"RECRUITING","enrollment_count":154,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT06765499","title":"The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"First People's Hospital of Hangzhou","has_results":false},{"nct_id":"NCT04240925","title":"Tolerability, Safety and Efficacy of Sigh Breaths During NIMV in Motor Neuron Disease","phase":"NA","overall_status":"UNKNOWN","enrollment_count":44,"lead_sponsor_name":"Ospedale San Raffaele","has_results":false},{"nct_id":"NCT04293484","title":"Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral Sclerosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","has_results":false},{"nct_id":"NCT03520517","title":"Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05299372","title":"Telemonitoring in NIV MND (OptNIVent)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Liverpool University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT07187388","title":"Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Nova Southeastern University","has_results":false},{"nct_id":"NCT03487263","title":"Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Implicit Bioscience","has_results":false},{"nct_id":"NCT03604822","title":"Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS","phase":"NA","overall_status":"UNKNOWN","enrollment_count":8,"lead_sponsor_name":"Alisa Apreleva","has_results":false},{"nct_id":"NCT03100110","title":"NeuroCognitive Communicator: Safety Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT03537807","title":"Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Biohaven Pharmaceuticals, Inc.","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}